Achilles Therapeutics Ownership | Who Owns Achilles Therapeutics?


OverviewFinancialsChart

Achilles Therapeutics Ownership Summary


Achilles Therapeutics is owned by 60.31% institutional investors, 6.52% insiders, and 33.17% retail investors. Syncona portfolio is the largest institutional shareholder, holding 27.42% of ACHL shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.05% of its assets in Achilles Therapeutics shares.

ACHL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAchilles Therapeutics60.31%6.52%33.17%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Syncona portfolio11.09M27.42%$12.64M
Bml capital management4.10M10.14%$4.67M
Fcpm iii services b.v.2.39M5.93%$1.95M
Redmile group1.61M3.99%$1.31M
Vestal point capital, lp1.50M3.72%$1.22M
Ikarian capital1.44M3.58%$1.18M
Artal group755.38K1.88%$615.63K
Renaissance682.73K1.69%$556.43K
Boothbay fund management420.48K1.04%$342.69K
Acadian asset management191.83K0.47%$218.00K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Syncona portfolio11.09M23.86%$12.64M
Bml capital management4.10M2.90%$4.67M
Fcpm iii services b.v.2.39M0.29%$1.95M
Ikarian capital1.44M0.20%$1.18M
Vestal point capital, lp1.50M0.09%$1.22M
Redmile group1.61M0.08%$1.31M
Artal group755.38K0.02%$615.63K
Boothbay fund management420.48K0.01%$342.69K
Brave asset management10.00K0.00%$11.40K
Virtu financial22.81K0.00%$19.00K

Top Buyers

HolderShares% AssetsChange
Ubs group65.70K-65.70K
Two sigma investments, lp21.48K-9.68K
Two sigma advisers, lp23.50K-5.60K
Virtu financial22.81K0.00%1.87K
Geode capital management21.59K--

Top Sellers

HolderShares% AssetsChange
Stempoint capital lp---1.39M
Baker bros. advisors lp---1.11M
Renaissance682.73K0.00%-323.02K
Forefront analytics---95.44K
Acadian asset management191.83K0.00%-59.00K

New Positions

HolderShares% AssetsChangeValue
Ubs group65.70K-65.70K$53.55K

Sold Out

HolderChange
Qube research-73.00
Ica group wealth management-400.00
Bank of america corp /de/-1.09K
Global retirement partners-2.00K
Arcadia investment management corp/mi-3.00K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202422-15.38%24,338,9659.69%601.99%8-3-50.00%
Jun 30, 202426-16.13%22,188,649-5.62%551.61%8-55.56%6-25.00%
Mar 31, 20243163.16%23,510,4557.93%581.98%18125.00%8100.00%
Dec 31, 20231911.76%21,782,17010.61%542.23%833.33%4-
Sep 30, 2023176.25%19,692,035-0.48%491.99%650.00%4-33.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index21.59K0.05%-
Blackstone Alternative Multi-Strategy I100.000.00%-

ACHL Ownership FAQ


Who Owns Achilles Therapeutics?

Achilles Therapeutics shareholders are primarily institutional investors at 60.31%, followed by 6.52% insiders and 33.17% retail investors. The average institutional ownership in Achilles Therapeutics's industry, Biotech Stocks , is 109.70%, which Achilles Therapeutics falls below.

Who owns the most shares of Achilles Therapeutics?

Achilles Therapeutics’s largest shareholders are Syncona portfolio (11.09M shares, 27.42%), Bml capital management (4.1M shares, 10.14%), and Fcpm iii services b.v. (2.39M shares, 5.93%). Together, they hold 43.50% of Achilles Therapeutics’s total shares outstanding.

Does Blackrock own Achilles Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Achilles Therapeutics.

Who is Achilles Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Achilles Therapeutics’s biggest shareholder by percentage of total assets invested, with 23.86% of its assets in 11.09M Achilles Therapeutics shares, valued at 12.64M$.

Who is the top mutual fund holder of Achilles Therapeutics shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of Achilles Therapeutics shares, with 0.05% of its total shares outstanding invested in 21.59K Achilles Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools